M&A Transaction Database
Healthcare Healthtech & Medtech M&A Transactions
Mergers and acquisitions in the Healthcare Healthtech & Medtech sector.
Filters
58 shown
Technimark strengthens its healthcare manufacturing by acquiring Rage Custom Plastics, boosting its US footprint and blow molding capabilities. Backed by Oak Hill Capital and Pritzker Private Capital.
Prestige Consumer Healthcare acquires a $1.045B OTC portfolio including Breathe Right from Foundation Consumer Healthcare, sharpening Foundation's focus on Women's Health.
Guardant Health boosts liquid biopsy tech with MetaSight Diagnostics acquisition. Deal valued up to $150M, expanding early cancer detection and disease identification.
HouseWorks Holdings, backed by InTandem Capital Partners, acquires A Caring Experience Nursing Services, enhancing its home care services in New England.
Harrison Street Asset Management
Harrison Street Buys Connecticut Senior Housing AssetsHarrison Street Asset Management expands senior housing portfolio in Connecticut, partnering with LCB Senior Living in a strategic move for the growing sector.
Infosys strengthens U.S. healthcare market presence with the $465M acquisition of Optimum Healthcare IT, enhancing digital transformation and consulting services.
Shionogi & Co., Ltd. invests $2.5 billion in RADICAVA, building a rare disease platform and enhancing its ALS treatment offerings.
WTWH Media strengthens its healthcare media and events presence with the acquisition of HealthLeaders, aiming to connect more industry leaders and insights.
SV Health Investors secures EpiVax, a key player in immunogenicity risk assessment for pharma and biotech, enhancing drug development efficiency.
AI-native brokerage platform Gyde acquires Medicare agency Avid Health, accelerating its expansion and modernization of insurance distribution.
Sycamore Partners aims to double Walgreens' profitability to $4B following its $10B acquisition, implementing operational and cost-saving strategies.
Oury Medical expands orthopedic and spinal offerings with Cefimeca acquisition, backed by TAG Partners and ISALT. Enhances manufacturing and market reach.
Global pharma major Lupin Limited completes acquisition of VISUfarma B.V., significantly expanding its ophthalmology portfolio and European market reach.
Cyclerion Therapeutics
Korsana Biosciences Merges with Cyclerion, Secures $380MKorsana Biosciences and Cyclerion Therapeutics merge, backed by $380M financing. Focus on advancing Alzheimer's drug KRSA-028 and neurodegenerative pipeline.
Axsome Therapeutics
Axsome Therapeutics Acquires CNS Drug Candidate from TakedaAxsome Therapeutics secures global rights to balipodect, a novel PDE10A inhibitor, aiming to enhance its neuroscience portfolio for neuropsychiatric conditions.
CapVest Partners completes €10 billion acquisition of STADA Arzneimittel AG, a leading global healthcare company, from Bain Capital and Cinven.
Two Great Helms Stock
Two Great Helms Ownership Shift Amid Financial HeadwindsIconic Chinese herbal toothpaste maker Two Great Helms faces a controlling shareholder change amid declining profits. Potential acquirers identified.
SEMEIA
SEMEIA, HEALABS Merge: France's Telemonitoring LeaderSEMEIA and HEALABS unite to create a dominant French digital health group, enhancing remote patient care for over 35,000 individuals.
Danone strengthens its health and nutrition offerings by acquiring Huel, a leading UK-based protein and meal replacement brand. Learn more about the deal.
IKS Health strategically acquires ThinkDTM, bolstering patient access with AI and product design expertise. Learn how this enhances healthcare delivery.
DaySmart Software enhances its international footprint and beauty/wellness software offerings through the strategic acquisition of Slick Software.
Biogen secures Apellis Pharmaceuticals in a $5.6 billion deal, enhancing its immunology and rare disease offerings with two approved therapies and expanding nephrology reach.
Eli Lilly and Company announces $6.3 billion acquisition of Centessa Pharmaceuticals, expanding its neuroscience focus on sleep-wake disorder treatments.
Playlist and EGYM unite in a $7.5 billion merger, forming a global fitness and wellness leader with integrated technology and extensive market reach.
Biogen Inc. secures Apellis Pharmaceuticals for $5.6 billion, enhancing its rare disease and immunology portfolio with key therapies for kidney conditions and macular degeneration.
CareHub
CareHub Expands Italian Diagnostics Network with AcquisitionsCareHub, supported by Quadrivio Group, grows its Italian diagnostic clinics through multiple acquisitions, aiming for significant revenue growth and market leadership.
Creas Impacto II backs Desconect@'s expansion in adolescent mental health services, addressing digital addiction and well-being challenges in Spain.
Palladium Equity Partners to acquire DME Express, a leading hospice medical equipment provider. Learn about this strategic healthcare services acquisition.
Viventium
Viventium Acquires Perks4Care to Boost Home Care TechLLR Partners-backed Viventium integrates Perks4Care's caregiver rewards platform, strengthening its position in the expanding home healthcare technology sector.
Columna Capital in exclusive talks to buy Evidenze for €150M. Learn about the deal, Evidenze's services, and market implications for healthcare PE.
CVC Capital Partners submits a $12.6B non-binding offer to acquire full control of Italian pharmaceutical firm Recordati, signaling a major European healthcare buyout.
Collectly enhances its AI patient financial platform by acquiring Pledge Health, aiming to automate the entire healthcare revenue cycle from pre-service to payment.
Wellness giant Herbalife acquires personalized nutrition startup Bioniq for up to $150M, enhancing its data-driven health platform.
Gilead Sciences acquires Ouro Medicines for $1.675B upfront, plus milestones, to advance its autoimmune T cell therapy pipeline.
Cerebral enhances its digital health offerings by acquiring Inflow, a specialized ADHD support app, to provide continuous, personalized patient care.
Vimian Group AB enhances its companion animal diagnostics capabilities by acquiring I-Vet and Biofleet in Italy, a strategic move in a growing market.
Herbalife boosts its data-driven wellness strategy by acquiring Bioniq for up to $150M, enhancing personalized nutrition offerings globally.
CVC Capital Partners submits a €10.9 billion non-binding offer to acquire Recordati S.p.A., aiming to take the Italian pharmaceutical company private.
Sensio
Sensio Acquires ISECO, Bolstering European Care Tech PresenceNordic Capital-backed Sensio expands its European footprint by acquiring Spanish care tech leader ISECO, enhancing its market position and service offerings.
Danone strengthens its functional nutrition portfolio by acquiring Huel for $1.15 billion, tapping into the booming market for convenient, plant-based meal solutions.
Never Miss a Deal
Get weekly investment intelligence. Free forever.